- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01558479
The Parkinson's Genetic Research Study (PaGeR)
The Parkinson's Genetic Research Study (PaGeR)
Study Overview
Status
Conditions
Detailed Description
PaGeR is focusing on families in which two or more people have been diagnosed with PD. Past research suggests that such "multiplex" families might hold the key to the discovery of new PD genes.
To take part in PaGeR, participants will be asked to complete a questionnaire and to undergo an interview, a neurological exam, a short memory test, and a blood draw. Enrollment in the study usually takes between one and two hours. There is no cost to participate, and all study information is kept strictly confidential.
There are a number of designated sites across the country where families can enroll. However, for family members who are unable to travel to one of these sites, other arrangements can be made.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Jennifer Pate
- Phone Number: 1-855-646-4221
Study Contact Backup
- Name: Khryss Capawa
- Phone Number: (206) 277-3956
- Email: kcapawa@uw.edu
Study Locations
-
-
Georgia
-
Atlanta, Georgia, United States, 30329
- Recruiting
- Emory University/ Wesley Woods Health Center
-
Contact:
- Barbara Sommerfield, MSN, RN
- Phone Number: 404-728-6944
- Email: bsommer@emory.edu
-
-
Ohio
-
Cincinnati, Ohio, United States, 45267
- Recruiting
- University of Cincinnati
-
Contact:
- Jatue Krier
- Phone Number: 513-558-0169
- Email: katie.krier@uc.edu
-
-
Oregon
-
Portland, Oregon, United States, 97239
- Recruiting
- Portland VA Medical Center
-
Contact:
- Susan O'Connor
- Phone Number: 53262 503-220-8262
-
-
Washington
-
Seattle, Washington, United States, 98108
- Recruiting
- VA Puget Sound Health Care System
-
Contact:
- Jennifer Pate
- Phone Number: 855-646-4221
-
Principal Investigator:
- Cyrus Zabetian, MD, MS
-
Seattle, Washington, United States, 98118
- Recruiting
- University of Washington
-
Contact:
- Jennifer Pate
- Phone Number: 855-646-4221
-
Principal Investigator:
- Cyrus Zabetian, MD, MS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Over 18 years of age
- Member of a family in which there are two or more living individuals who have been diagnosed with Parkinson's disease
Exclusion Criteria:
- Under 18 years of age
Study Plan
How is the study designed?
Design Details
- Observational Models: Family-Based
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
|---|
|
Case
Has a diagnosis of Parkinson's disease
|
|
Control
No diagnosis of Parkinson's disease
|
|
Family Member
Has a family history of Parkinson's disease.
Can be affected or unaffected with Parkinson's disease
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Cyrus Zabetian, MD, MS, University of Washington, VA Puget Sound Health Care System
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 36777
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson's Disease
-
EicOsis Human Health Inc.University of California, Davis; Michael J. Fox Foundation for Parkinson's...RecruitingParkinson's Disease (PD)United States
-
University of Kansas Medical CenterNot yet recruitingParkinson's Disease (PD)United States
-
AbbVieRecruiting
-
University Hospital Schleswig-HolsteinUniversity of Kiel; University of Cologne; University Hospital, Bonn; Philipps...Not yet recruitingParkinson's Disease (PD)
-
InvicroMerck Sharp & Dohme LLCRecruitingParkinson's Disease | Parkinson's Disease (PD) | Parkinson's Disease (Disorder)United States
-
Ohio State UniversityCompletedParkinson's Disease | Parkinson Disease | Idiopathic Parkinson Disease | Idiopathic Parkinson's Disease | Parkinson Disease, Idiopathic | Parkinson's Disease, IdiopathicUnited States
-
Assistance Publique - Hôpitaux de ParisFrance Parkinson AssociationUnknownHealthy Controls | Parkinson's Disease With LRRK2 Mutation | Parkinson's Disease Without LRRK2 MutationFrance
-
Guangzhou Henovcom Bioscience Co. Ltd.Frontage Clinical Services, Inc.Active, not recruitingParkinson's Disease (PD)United States
-
Universitätsklinikum Hamburg-EppendorfUniversity of TwenteRecruitingParkinson's Disease | Deep Brain StimulationGermany
-
Mission TherapeuticsMichael J. Fox Foundation for Parkinson's Research; Parkinson's UKRecruitingParkinson's Disease (PD) | Early Stage Parkinson's Disease | Mild to Moderate Parkinson's DiseaseUnited Kingdom